VivoSeq
Other

Mechanically Ventilated Patients

0

Pipeline Programs

2

Active Trials

3

Companies Involved

Mechanically Ventilated Patients is an early-stage landscape with 0 programs across 3 companies. The most active players are Novartis, Sanofi, Cardeas Pharma.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

64/100

Attrition Rate

21/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

19

clinical trials

Completed7 · 37%
Unknown status6 · 32%
Withdrawn3 · 16%
Not yet recruiting1 · 5%
Terminated1 · 5%
Recruiting1 · 5%

Trial Activity

19 trials

Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)